Sign in
4

Changes in Ownership

INOVIO PHARMACEUTICALS, INC. Filed Acc 0001770390-26-000005

Chief Scientific Officer gave up 2,163 shares (to pay taxes)

  • Chief Scientific Officer acquired 6,027 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Humeau Laurent · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-05-20 Exercise or conversion : show line 1 in the form +6,027 48,986 D
2026-05-20 Shares withheld for taxes : show line 2 in the form −2,163 $1.23 $2,660 46,823 D

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2026-05-20 Exercise or conversion : show line 3 in the form Restricted Stock Unit −6,027 12,054 D
2026-05-20 Grant or award : show line 4 in the form Common Stock Option +34,160 34,160 D
2026-05-20 Grant or award : show line 5 in the form Restricted Stock Unit +27,440 27,440 D
Loading xslF345X06/wk-form4_1779393944.xml…